MENU
BWAY
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

BWAY stock forecast, quote, news & analysis

BrainsWay Ltd is engaged in advanced noninvasive neurostimulation treatments for mental health disorders... Show more

Interact to see
Advertisement
A.I.Advisor
published price charts
BWAY
Daily Signal:
Gain/Loss:
A.I.Advisor
a Summary for BWAY with price predictions
Oct 22, 2026

Momentum Indicator for BWAY turns negative, indicating new downward trend

BWAY saw its Momentum Indicator move below the 0 level on October 22, 2026. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 100 similar instances where the indicator turned negative. In 83 of the 100 cases, the stock moved further down in the following days. The odds of a decline are at 83%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 43 of 55 cases where BWAY's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 78%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where BWAY declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 77%.

The Aroon Indicator for BWAY entered a downward trend on October 14, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where BWAY's RSI Indicator exited the oversold zone, 19 of 20 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 90%.

The Moving Average Convergence Divergence (MACD) for BWAY just turned positive on October 19, 2026. Looking at past instances where BWAY's MACD turned positive, the stock continued to rise in 38 of 50 cases over the following month. The odds of a continued upward trend are 76%.

Following a +5.16% 3-day Advance, the price is estimated to grow further. Considering data from situations where BWAY advanced for three days, in 221 of 264 cases, the price rose further within the following month. The odds of a continued upward trend are 84%.

BWAY may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is 62 (best 1 - 100 worst), indicating steady price growth. BWAY’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 62 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is 65 (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 66 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock slightly better than average.

The Tickeron Valuation Rating of 86 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.813) is normal, around the industry mean (2.874). P/E Ratio (45.760) is within average values for comparable stocks, (2.324). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (11.052). Dividend Yield (0.000) settles around the average of (0.009) among similar stocks. P/S Ratio (8.681) is also within normal values, averaging (40.124).

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Abbott Laboratories (NYSE:ABT), Medtronic plc (NYSE:MDT), Boston Scientific Corp (NYSE:BSX), Edwards Lifesciences Corp (NYSE:EW).

Industry description

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

Market Cap

The average market capitalization across the Medical/Nursing Services Industry is 5.7B. The market cap for tickers in the group ranges from 837 to 177.38B. ABT holds the highest valuation in this group at 177.38B. The lowest valued company is DHAI at 837.

High and low price notable news

The average weekly price growth across all stocks in the Medical/Nursing Services Industry was -2%. For the same Industry, the average monthly price growth was -11%, and the average quarterly price growth was -10%. CTSO experienced the highest price growth at 100%, while LUCD experienced the biggest fall at -37%.

Volume

The average weekly volume growth across all stocks in the Medical/Nursing Services Industry was -23%. For the same stocks of the Industry, the average monthly volume growth was -7% and the average quarterly volume growth was -7%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 48
P/E Growth Rating: 49
Price Growth Rating: 62
SMR Rating: 89
Profit Risk Rating: 95
Seasonality Score: 13 (-100 ... +100)
View a ticker or compare two or three
BWAY
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

a developer and manufacturer of deep transcranial magnetic stimluation systems, novel, noninvasive medical devices

Industry MedicalNursingServices

Industry
Medical Specialties
Address
16 Hartum Street
Phone
+972 25824030
Employees
129
Web
https://www.brainsway.com
Momentum Indicator for BWAY turns negative, indicating new downward trend